{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T08:10:06Z","timestamp":1789027806611,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Childs Nerv Syst"],"DOI":"10.1007\/s00381-026-07464-w","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:55:47Z","timestamp":1789026947000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of trametinib use in pediatric brain tumors in a low- to middle-income country"],"prefix":"10.1007","volume":"42","author":[{"given":"Roula","family":"Farah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Farah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Charro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Bedran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romy","family":"Daccache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Bouffet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"issue":"2","key":"7464_CR1","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s11060-018-2971-9","volume":"140","author":"M Kondyli","year":"2018","unstructured":"Kondyli M, Larouche V, Saint-Martin C, Ellezam B, Pouliot L, Sinnett D et al (2018) Trametinib for progressive pediatric low-grade gliomas. J Neurooncol 140(2):435\u2013444","journal-title":"J Neurooncol"},{"issue":"3","key":"7464_CR2","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s11060-020-03640-3","volume":"149","author":"F Selt","year":"2020","unstructured":"Selt F, van Tilburg CM, Bison B, Sievers P, Harting I, Ecker J et al (2020) Response to trametinib treatment in progressive pediatric low-grade glioma patients. J Neurooncol 149(3):499\u2013510","journal-title":"J Neurooncol"},{"issue":"8","key":"7464_CR3","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro-oncol 23(8):1231\u20131251","journal-title":"Neuro-oncol"},{"issue":"2","key":"7464_CR4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s11060-020-03592-8","volume":"149","author":"N Manoharan","year":"2020","unstructured":"Manoharan N, Choi J, Chordas C, Zimmerman MA, Scully J, Clymer J et al (2020) Trametinib for the treatment of recurrent\/progressive pediatric low-grade glioma. J Neurooncol 149(2):253\u2013262","journal-title":"J Neurooncol"},{"issue":"1","key":"7464_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6442-2","volume":"19","author":"S Perreault","year":"2019","unstructured":"Perreault S, Larouche V, Tabori U, Hawkin C, Lipp\u00e9 S, Ellezam B et al (2019) A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK\/ERK pathway: TRAM-01. BMC Cancer 19(1):1250","journal-title":"BMC Cancer"},{"issue":"8","key":"7464_CR6","doi-asserted-by":"publisher","first-page":"e730","DOI":"10.1097\/MPH.0000000000001819","volume":"42","author":"MR Paul","year":"2020","unstructured":"Paul MR, Pehlivan KC, Milburn M, Yeh-Nayre L, Elster J, Crawford JR (2020) Trametinib-based treatment of pediatric CNS tumors: a single institutional experience. J Pediatr Hematol Oncol 42(8):e730","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"7464_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00280-025-04761-0","volume":"95","author":"L Pagnot","year":"2025","unstructured":"Pagnot L, Granger I, Guitton J, Favier B, Ceraulo A, Faure-Conter C et al (2025) Real-world pharmacokinetics of trametinib in pediatric low-grade glioma. Cancer Chemother Pharmacol 95(1):35","journal-title":"Cancer Chemother Pharmacol"},{"issue":"3","key":"7464_CR8","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1200\/JCO.22.01000","volume":"41","author":"E Bouffet","year":"2023","unstructured":"Bouffet E, Geoerger B, Moertel C, Whitlock JA, Aerts I, Hargrave D et al (2023) Efficacy and safety of trametinib monotherapy or in combination with dabrafenib in pediatric BRAF V600-mutant low-grade glioma. J Clin Oncol 41(3):664\u201374","journal-title":"J Clin Oncol"},{"key":"7464_CR9","unstructured":"Bank W. Lebanon Poverty and Equity Assessment 2024\u202f: (2025) Weathering a protracted crisis [Internet]. World Bank. Available from: https:\/\/documents.worldbank.org\/en\/publication\/documents-reports\/documentdetail\/099052224104516741"},{"key":"7464_CR10","doi-asserted-by":"crossref","unstructured":"Fangusaro J, Onar-Thomas A, Young Poussaint T, Lensing S, Ligon AH, Lindeman N, et al.\u00a0 (2025) A phase 2 PBTC study of selumetinib for recurrent\/progressive pediatric low-grade glioma: strata 2, 5, and 6 with long-term outcomes on strata 1, 3, and 4. Neuro-Oncol. noaf065.","DOI":"10.1093\/neuonc\/noaf065"},{"key":"7464_CR11","doi-asserted-by":"publisher","unstructured":"Abu Laban D, Alsharif A, Al-Hussaini M, Obeidat M, Maraqa B, Alzoubi Q, et al. (2024) BRAF\/MEK inhibitors use for pediatric gliomas; real world experience from a resource-limited country. Front Oncol [Internet].\u00a0 [cited 2025 Sept 4];14. Available from: https:\/\/www.frontiersin.org\/journals\/oncology\/articles\/https:\/\/doi.org\/10.3389\/fonc.2024.1417484\/full","DOI":"10.3389\/fonc.2024.1417484\/full"},{"key":"7464_CR12","doi-asserted-by":"publisher","DOI":"10.3171\/2016.9.PEDS16328","author":"C Miller","year":"2017","unstructured":"Miller C, Guillaume D, Dusenbery K, Clark HB, Moertel C (2017) Report of effective trametinib therapy in 2 children with progressive hypothalamic optic pathway pilocytic astrocytoma: documentation of volumetric response. Journal of Neurosurgery: Pediatrics. https:\/\/doi.org\/10.3171\/2016.9.PEDS16328","journal-title":"Journal of Neurosurgery: Pediatrics"},{"issue":"7","key":"7464_CR13","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S1470-2045(19)30277-3","volume":"20","author":"J Fangusaro","year":"2019","unstructured":"Fangusaro J, Onar-Thomas A, Young Poussaint T, Wu S, Ligon AH, Lindeman N et al (2019) Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial. Lancet Oncol 20(7):1011\u201322","journal-title":"Lancet Oncol"},{"issue":"12","key":"7464_CR14","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1056\/NEJMoa2303815","volume":"389","author":"E Bouffet","year":"2023","unstructured":"Bouffet E, Hansford JR, Garr\u00e8 ML, Hara J, Plant-Fox A, Aerts I et al (2023) Dabrafenib plus trametinib in pediatric glioma with BRAF V600 mutations. N Engl J Med 389(12):1108\u201320","journal-title":"N Engl J Med"},{"issue":"4","key":"7464_CR15","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1159\/000539374","volume":"240","author":"R Friedland","year":"2024","unstructured":"Friedland R, Gluck M, Amitay-Laish I, Toledano H (2024Aug) Cutaneous reactions in pediatric patients treated with MEK inhibitors: a retrospective single-center study. Dermatol Basel Switz 240(4):565\u2013571","journal-title":"Dermatol Basel Switz"},{"key":"7464_CR16","doi-asserted-by":"publisher","DOI":"10.1200\/GO-25-00023","volume":"11","author":"E Al Badarin","year":"2025","unstructured":"Al Badarin E, Chamdine O, Elayadi M, Al-Battashi A, Al Nuaimi M, Alshamsi ET, Hessissen L, Al-Tarrah H, Maher E, Farah R, Maaz A (2025) Expanding the pediatric neuro-oncology teleconference experience: from twinning to international cases discussions. JCO Glob Oncol 11:e2500023","journal-title":"JCO Glob Oncol"},{"key":"7464_CR17","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s11060-024-04624-3","volume":"167","author":"E Lalancette","year":"2024","unstructured":"Lalancette E (2024) Impact of trametinib on the neuropsychological profile of NF1 patients | Journal of Neuro-Oncology. J Neurooncol 167:447\u2013454","journal-title":"J Neurooncol"},{"issue":"12","key":"7464_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28690","volume":"67","author":"RK Peterson","year":"2020","unstructured":"Peterson RK, McKeown T, Tabori U, Bartels U, Bouffet E, Janzen L (2020) Neuropsychological impact of trametinib in pediatric low-grade glioma: a case series. Pediatr Blood Cancer 67(12):e28690","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"7464_CR19","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00401-017-1743-5","volume":"134","author":"P Euskirchen","year":"2017","unstructured":"Euskirchen P, Bielle F, Labreche K, Kloosterman WP, Rosenberg S, Daniau M, Schmitt C, Masliah-Planchon J, Bourdeaut F, Dehais C, Marie Y (2017) Same-day genomic and epigenomic diagnosis of brain tumors using real-time nanopore sequencing. Acta Neuropathol 134(5):691\u2013703","journal-title":"Acta Neuropathol"}],"container-title":["Child's Nervous System"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-026-07464-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00381-026-07464-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-026-07464-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:55:50Z","timestamp":1789026950000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00381-026-07464-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7464"],"URL":"https:\/\/doi.org\/10.1007\/s00381-026-07464-w","relation":{},"ISSN":["1433-0350"],"issn-type":[{"value":"1433-0350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"assertion":[{"value":"1 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors confirm that written consent for submission and publication of this case series, including images and associated text, have been obtained from the patients in line with COPE guidance.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"357"}}